PET finds hypometabolism in healthy brains that may indicate pre-Alzheimer’s disease.
PET images detected an association between hypometabolism and amyloid in brains of people with pre-Alzheimer’s who don’t show any signs of cognitive decline, according to presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 annual meeting.
The amyloid plaque build-up in the brain in Alzheimer’s is known, but now there appears to be a connection between the amyloid burden and hypometabolism of neurons in parts of the brain that have been associated with Alzheimer’s disease.
“Previous studies indicate that hypometabolism of this same pattern is present in people who have abnormalities of the gene apolipoprotein E, or APOE,” Val J. Lowe, MD, professor of radiology at Mayo Clinic Cancer Center, said in a release. “Hypometabolism does appear to be an early harbinger of the disease before dementia sets in.”.
Researchers from the Mayo Clinic Study of Aging studied PET images of 617 cognitively normal subjects. Each subject first underwent imaging with the amyloid-binding radionuclide imaging agent C-11 Pittsburgh compound B (PiB), followed an hour later with a second exam which used F018 fluorodeoxyglucose (FDG).
The researchers found that there was significant hypometabolism in brain regions classically associated with Alzheimer’s disease, including the angular gyrus and posterior cingulate.
The researchers will continue to follow the subjects to see if they progress to Alzheimer’s disease, and to study the ones do not develop the disease but do have amyloid in their brain.
Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa
June 21st 2024Initial detection of metastatic prostate cancer via 68Ga-PSMA-11 PET/CT was significantly associated with PSA values > 20 ng/ml, ISUP grade > 3 and MRI T-stage > 3, according to research presented recently at the SNMMI conference.
SNMMI: Can Ultra-Low Dose PET Supplant the Need for CT Attenuation Correction?
June 11th 2024Ultra-low dosing with long axial field-of-view positron emission tomography (PET) scanners facilitates qualitative PET imaging at a more than 50 percent reduction of conventional radiation dosing with PET, according to new research presented at the SNMMI 2024 conference.
SNMMI: AI May Enhance Detection and Risk Assessment for Multiple Cancers on Whole-Body PET/CT Scans
June 10th 2024Deep transfer learning may elevate the capability of whole-body PET/CT scans to diagnose multiple cancers, ranging from breast cancer and lung cancer to melanoma and prostate cancer, according to new research presented at the SNMMI conference.
Siemens Healthineers Announces FDA Clearance for New PET/CT System at SNMMI Meeting
June 9th 2024Emphasizing enhanced time-of-flight performance and an energy-efficient design, the Biograph Trinion PET/CT system can reportedly be utilized for a variety of imaging needs, ranging from theranostic applications to neurology imaging.